Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance.
Nevo J, Mattila E, Pellinen T, Yamamoto DL, Sara H, Iljin K, Kallioniemi O, Bono P, Heikkilä P, Joensuu H, Wärri A, Ivaska J.
Nevo J, et al. Among authors: iljin k.
Clin Cancer Res. 2009 Nov 1;15(21):6570-81. doi: 10.1158/1078-0432.CCR-09-0773. Epub 2009 Oct 13.
Clin Cancer Res. 2009.
PMID: 19825952